Policy Read Out: Medical Security Law of the People's Republic of Chinaโ
The Medical Security Law of the People's Republic of China was adopted by vote at the 24th Session of the Standing Committee of the 14th National People's Congress on August 28, 2026, and will enter into force on January 1, 2027. As the first foundational and overarching law in China's medical security field, it consists of 7 chapters and 56 articles, marking the maturation and finalization of China's medical security system and serving as an important milestone in advancing the rule of law in China's social security system. This law systematically summarizes the achievements of medical insurance reform in recent years and elevates systems such as centralized volume-based procurement, designated-provider agreement management, fund supervision, and credit management into legal norms, and will have a profound impact on pharmaceutical companies' market access, business operations, and compliance management.
ใไธญๅไบบๆฐๅ ฑๅๅฝๅป็ไฟ้ๆณใๅทฒไบ2026ๅนด8ๆ28ๆฅ็ฑ็ฌฌๅๅๅฑๅ จๅฝไบบๆฐไปฃ่กจๅคงไผๅธธๅกๅงๅไผ็ฌฌไบๅๅๆฌกไผ่ฎฎ่กจๅณ้่ฟ๏ผ่ช2027ๅนด1ๆ1ๆฅ่ตทๆญฃๅผๆฝ่กใไฝไธบๆๅฝๅป็ไฟ้้ขๅ้ฆ้จๅบ็กๆงใ็ป้ขๆงๆณๅพ๏ผ่ฏฅๆณๅ ฑ7็ซ 56ๆก๏ผๆ ๅฟ็ๆๅฝๅป็ไฟ้ๅถๅบฆ่ตฐๅๆ็ๅฎๅ๏ผๆฏๆๅฝ็คพไผไฟ้ไฝ็ณปๅปบ่ฎพๆณๆฒปๅ็้่ฆ้็จ็ขไบไปถใ่ฟ้จๆณๅพ็ณป็ปๆป็ปไบ่ฟๅนดๆฅๅปไฟๆน้ฉๆๆ๏ผๅฐ้ไธญๅธฆ้้่ดญใๅฎ็นๅ่ฎฎ็ฎก็ใๅบ้็็ฎกใไฟก็จ็ฎก็็ญๅถๅบฆไธๅไธบๆณๅพ่ง่๏ผๅฏนๅป่ฏไผไธ็ๅธๅบๅๅ ฅใไธๅก่ฟ่ฅๅๅ่ง็ฎก็ๅฐไบง็ๆทฑ่ฟๅฝฑๅใ
The newly promulgated Medical Security Law marks the elevation of medical insurance reform achievements into legal norms. The Legal Working Group and the Healthcare Working Group of the American Chamber of Commerce in China (AmCham China) have invited relevant legal experts to systematically interpret the legislative background and regulatory framework, break down key provisions such as the statutory normalization of centralized procurement, designated-provider management, fund supervision, and credit and information protection; analyze, with case studies, legal red lines including illegal use of funds, insurance fraud, violations in centralized procurement bidding, and commercial bribery in procurement and sales; and propose compliance recommendations in three areasโgovernment affairs, legal and compliance, and business operationsโto help pharmaceutical companies seize the transition window, improve their compliance systems, and respond to the new stage of law-based medical insurance governance.
ใๅป็ไฟ้ๆณใๆๆฐ้ขๅธ๏ผๆ ๅฟ็ๅปไฟๆน้ฉๆๆไธๅไธบๆณๅพ่ง่ใไธญๅฝ็พๅฝๅไผๆณๅพๅทฅไฝ็ป่ๅๅป็ๅทฅไฝ็ป่ฏทๆฅ็ธๅ ณๆณๅพไธๅฎถๅฐ็ณป็ป่งฃ่ฏป็ซๆณ่ๆฏไธ่งๅถๆกๆถ๏ผๆ่งฃ้้ๆณๅฎๅธธๆใๅฎ็น็ฎก็ใๅบ้็็ฎกใไฟก็จไธไฟกๆฏไฟๆค็ญๅ ณ้ฎๆกๆฌพ๏ผ็ปๅๆกไพ่งฃๆ่ฟๆณไฝฟ็จๅบ้ใๆฌบ่ฏ้ชไฟใ้้ๆๆ ่ฟ่งใ่ดญ้ๅไธ่ดฟ่ต็ญๆณๅพ็บข็บฟ๏ผๅนถไปๆฟๅบไบๅกใๆณๅกๅ่งใไธๅก่ฟ่ฅไธๆน้ขๆๅบๅ่งๅปบ่ฎฎ๏ผๅฉๅๅป่ฏไผไธๆๆก่ฟๆธกๆ็ชๅฃใๅฎๅๅ่งไฝ็ณปใๅบๅฏนๅปไฟๆณๆฒปๅๆฐ้ถๆฎตใ
All companies interested in the Medical Security Law are welcome to attend!
ๆฌข่ฟๆๆๅ ณๆณจใๅป็ไฟ้ๆณใ็ไผไธๅๅ ๏ผ
Event Details:
- Venue: AmCham China Washington Room
- Date: October 20, 2026
- Time: 2:30 PM - 4:00 PM (Registration start from 2:30pm - 2:40pm)
- Language: Chinese
- Format: Hybrid
- Contact: Ada Yang, ayang@amchamchina.org; Pedro Cheng, pcheng@amchamchina.org
Notes:
- Registration closes at 5 PM, October 19.
- Tickets are non-refundable after 12 PM of October 19.
- Please use your company email address for registration.
- Due to limited capacity, we are unable to accommodate walkโin participants.
